SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001396814-17-000024
Filing Date
2017-08-02
Accepted
2017-08-02 15:10:58
Documents
72
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pcrx-6302017x10xq.htm 10-Q 1052679
2 EXHIBIT 31.1 pcrx-63017xex311.htm EX-31.1 14789
3 EXHIBIT 31.2 pcrx-63017xex312.htm EX-31.2 14806
4 EXHIBIT 32.1 pcrx-63017xex321.htm EX-32.1 5629
5 EXHIBIT 32.2 pcrx-63017xex322.htm EX-32.2 5537
12 paciralogoa06.jpg GRAPHIC 63011
  Complete submission text file 0001396814-17-000024.txt   5864161

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pcrx-20170630.xml EX-101.INS 1168920
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20170630.xsd EX-101.SCH 50638
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20170630_cal.xml EX-101.CAL 71787
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20170630_def.xml EX-101.DEF 206949
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20170630_lab.xml EX-101.LAB 641382
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20170630_pre.xml EX-101.PRE 350273
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 17999582
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1